2 min read
Individualized mRNA vaccine triggers lasting T cell immunity in breast cancer patients
An mRNA vaccine targeting neoantigens induced strong, long-lasting T cell responses in triple-negative breast cancer patients. Most remained cancer-free for years, with insights into why a few relapsed.